Illumina, Inc. (ILMN) News
Filter ILMN News Items
ILMN News Results
|Event/Time||Symbol||Company||News Detail||Start||End||Change||POWR Rating|
|Loading, please wait...|
Latest ILMN News From Around the Web
Below are the latest news stories about Illumina Inc that investors may wish to consider to help them evaluate ILMN as an investment opportunity.
Top Analyst Upgrades and Downgrades: Delta, Hasbro, Illumina, Lululemon, Micron, Nike, Penn National, Shopify, Southwest, Starbucks, Zynga and More
No summary available.
Gene Expression Market Reflect a Holistic Expansion With Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Bio-Rad Laboratories, OriGene Technologies, Illumina, Inc., QIAGEN
A report by The Insight Partner's on the Gene Expression Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the
Global Function Driven Metagenomics Market Projected To Show Strong Growth By 2026 | |Danaher; Merck KGaA; Illumina, Inc.; Thermo Fisher Scientific Inc.; QIAGEN; F. Hoffmann-La Roche Ltd; Novogene Corporation
The numerous recent developments, products launches, research, joint ventures, mergers and acquisitions in the Function Driven Metagenomics market which is changing the face healthcare industry.We at Data Bridge Market Research understand what is important in the Function Driven
Deals and Financings Illumina (ILMN) will acquire GRAIL (GRAL), an Illumina spin-out that is developing an early screening test for multiple forms of cancer, for $8 billion in cash and stock (see story). In 2017, GRAIL bought Cirina, a Hong Kong-San Francisco liquid biopsy company cofounded by Dr. Dennis Lo,...
SAN DIEGO--(BUSINESS WIRE)---- $ILMN #ILMN--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2020 following the close of market on Thursday, October 29, 2020. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results. Conference Call Details
Illumina's (ILMN) $8B takeout of liquid biopsy developer GRAIL, which it formed in 2016 with funding assistance from the likes of Bill Gates and Jeff Bezos, may be a watershed event for its use in cancer detection and management.It is developing a multi-cancer early detection test called Galleri that detects...
The CEOs of the two companies told STAT it would take time for investors to understand the advantages of combining the two firms.
It's been a little wild lately for Pacific Biosciences (PACB) ("PacBio"). While there have been several strong names in life sciences over the past three months and on a year-to-date basis, including companies like 10x Genomics (TXG), Berkeley Lights (BLI), and Nanostring (NSTG), PacBio has sprinted ahead about 125% since...
Illumina (ILMN) Illumina to Acquire GRAIL Conference Call September 21, 2020 8:00 A.M. ET Company Participants Jacquie Ross - Vice President, Investor Relations Francis deSouza - President and Chief Executive Officer Sam Samad - Chief Financial Officer Hans Bishop - Chief Executive Officer, GRAIL Conference Call Participants Doug Schenkel -...
Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Apple, Carvana, Illumina, NextEra, Nikola, Shake Shack, Teladoc, WPX Energy and More
No summary available.